Sensitive and viable quantification of inside-out signals for LFA-1 activation in human cytotoxic lymphocytes by flow cytometry

Journal of Immunological Methods

Volumn 366, Issue 1-2, 2011, Pages 106-118

  Theorell, Jakob ^a   Schlums, Heinrich ^a   Chiang, Samuel C C ^a   Huang, Terry Y ^a   Tattermusch, Anna ^a   Wood, Stephanie M ^a   Bryceson, Yenan T ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CMV; Cytotoxic T lymphocytes; Inside out signaling; LFA 1; NK cells; NKG2A

Indexed keywords

BETA2 INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CONFORMATIONAL TRANSITION; CYTOTOXIC LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOSURVEILLANCE; LEUKOCYTE; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TARGET CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD18; CELL DEGRANULATION; CHEMOKINE CCL4; CHEMOKINES; CYTOMEGALOVIRUS; FLOW CYTOMETRY; HUMANS; IMMUNOASSAY; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MICE; PROTEIN CONFORMATION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 79952315439     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2011.01.014     Document Type: Article

References (45)

1. Alter G., Malenfant J.M., Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 2004, 294:15.
2. Andre P., Anfossi N. Clinical analysis of human natural killer cells. Methods Mol. Biol. 2008, 415:291.
3. Beals C.R., Edwards A.C., Gottschalk R.J., Kuijpers T.W., Staunton D.E. CD18 activation epitopes induced by leukocyte activation. J. Immunol. 2001, 167:6113.
4. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., Koup R.A. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003, 281:65.
5. Betts M.R., Price D.A., Brenchley J.M., Lore K., Guenaga F.J., Smed-Sorensen A., Ambrozak D.R., Migueles S.A., Connors M., Roederer M., Douek D.C., Koup R.A. The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration. J. Immunol. 2004, 172:6407.
6. Bolton D.L., Roederer M. Flow cytometry and the future of vaccine development. Expert Rev. Vaccin. 2009, 8:779.
7. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 1998, 187:813.
8. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998, 391:795.
9. Bryceson Y.T., Long E.O. Line of attack: NK cell specificity and integration of signals. Curr. Opin. Immunol. 2008, 20:344.
10. Bryceson Y.T., March M.E., Barber D.F., Ljunggren H.G., Long E.O. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J. Exp. Med. 2005, 202:1001.
11. Bryceson Y.T., Rudd E., Zheng C., Edner J., Ma D., Wood S.M., Bechensteen A.G., Boelens J.J., Celkan T., Farah R.A., Hultenby K., Winiarski J., Roche P.A., Nordenskjold M., Henter J.I., Long E.O., Ljunggren H.G. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 2007, 110:1906.
12. Bryceson Y.T., Ljunggren H.G., Long E.O. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009, 114:2657.
13. Bryceson Y.T., Fauriat C., Nunes J.M., Wood S.M., Bjorkstrom N.K., Long E.O., Ljunggren H.G. Functional analysis of human NK cells by flow cytometry. Methods Mol. Biol. 2010, 612:335.
14. Chan J.R., Hyduk S.J., Cybulsky M.I. Detecting rapid and transient upregulation of leukocyte integrin affinity induced by chemokines and chemoattractants. J. Immunol. Methods 2003, 273:43.
15. Claus M., Greil J., Watzl C. Comprehensive analysis of NK cell function in whole blood samples. J. Immunol. Methods 2009, 341:154.
16. Dongworth D.W., Gotch F.M., Hildreth J.E., Morris A., McMichael A.J. Effects of monoclonal antibodies to the alpha and beta chains of the human lymphocyte function-associated (H-LFA-1) antigen on T lymphocyte functions. Eur. J. Immunol. 1985, 15:888.
17. Dransfield I., Hogg N. Regulated expression of Mg2+ binding epitope on leukocyte integrin alpha subunits. EMBO J. 1989, 8:3759.
18. Dransfield I., Cabanas C., Craig A., Hogg N. Divalent cation regulation of the function of the leukocyte integrin LFA-1. J. Cell Biol. 1992, 116:219.
19. Drbal K., Angelisova P., Cerny J., Hilgert I., Horejsi V. A novel anti-CD18 mAb recognizes an activation-related epitope and induces a high-affinity conformation in leukocyte integrins. Immunobiology 2001, 203:687.
20. Fauriat C., Long E.O., Ljunggren H.G., Bryceson Y.T. Regulation of human NK cell cytokine and chemokine productionby target cell recognition. Blood 2010, 115:2167.
21. Gillespie G.M., Wills M.R., Appay V., O'Callaghan C., Murphy M., Smith N., Sissons P., Rowland-Jones S., Bell J.I., Moss P.A. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J. Virol. 2000, 74:8140.
22. Hildreth J.E., Gotch F.M., Hildreth P.D., McMichael A.J. A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur. J. Immunol. 1983, 13:202.
23. Hogg N., Laschinger M., Giles K., McDowall A. T-cell integrins: more than just sticking points. J. Cell Sci. 2003, 116:4695.
24. Hoos A., Parmiani G., Hege K., Sznol M., Loibner H., Eggermont A., Urba W., Blumenstein B., Sacks N., Keilholz U., Nichol G. A clinical development paradigm for cancer vaccines and related biologics. J. Immunother. 2007, 30:1.
25. Kim M., Carman C.V., Springer T.A. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 2003, 301:1720.
26. Kim G.G., Donnenberg V.S., Donnenberg A.D., Gooding W., Whiteside T.L. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4h 51Cr-release assay. J. Immunol. Methods 2007, 325:51.
27. Kuijpers T.W., van de Vijver E., Weterman M.A., de Boer M., Tool A.T., van den Berg T.K., Moser M., Jakobs M.E., Seeger K., Sanal O., Unal S., Cetin M., Roos D., Verhoeven A.J., Baas F. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood 2009, 113:4740.
28. Lamoreaux L., Roederer M., Koup R. Intracellular cytokine optimization and standard operating procedure. Nat. Protoc. 2006, 1:1507.
29. Lanier L.L. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 2008, 9:495.
30. Liu D., Bryceson Y.T., Meckel T., Vasiliver-Shamis G., Dustin M.L., Long E.O. Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. Immunity 2009, 31:99.
31. Lochmatter P., Zawodniak A., Pichler W.J. In vitro tests in drug hypersensitivity diagnosis. Immunol. Allergy Clin. North Am. 2009, 29:537.
32. Lum A.F., Green C.E., Lee G.R., Staunton D.E., Simon S.I. Dynamic regulation of LFA-1 activation and neutrophil arrest on intercellular adhesion molecule 1 (ICAM-1) in shear flow. J. Biol. Chem. 2002, 277:20660.
33. Luque A., Gomez M., Puzon W., Takada Y., Sanchez-Madrid F., Cabanas C. Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common beta 1 chain. J. Biol. Chem. 1996, 271:11067.
34. Malinin N.L., Zhang L., Choi J., Ciocea A., Razorenova O., Ma Y.Q., Podrez E.A., Tosi M., Lennon D.P., Caplan A.I., Shurin S.B., Plow E.F., Byzova T.V. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat. Med. 2009, 15:313.
35. Marcenaro S., Gallo F., Martini S., Santoro A., Griffiths G.M., Aricó M., Moretta L., Pende D. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood 2006, 108:2316.
36. Michaelsson J., Teixeira de Matos C., Achour A., Lanier L.L., Karre K., Soderstrom K. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J. Exp. Med. 2002, 196:1403.
37. Miedema F., Tetteroo P.A., Hesselink W.G., Werner G., Spits H., Melief C.J. Both Fc receptors and lymphocyte-function-associated antigen 1 on human T gamma lymphocytes are required for antibody-dependent cellular cytotoxicity (killer cell activity). Eur. J. Immunol. 1984, 14:518.
38. Oliveira J.B., Notarangelo L.D., Fleisher T.A. Applications of flow cytometry for the study of primary immune deficiencies. Curr. Opin. Allergy Clin. Immunol. 2008, 8:499.
39. Robinson M.K., Andrew D., Rosen H., Brown D., Ortlepp S., Stephens P., Butcher E.C. Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events. J. Immunol. 1992, 148:1080.
40. Sanchez-Madrid F., Krensky A.M., Ware C.F., Robbins E., Strominger J.L., Burakoff S.J., Springer T.A. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc. Natl Acad. Sci. USA 1982, 79:7489.
41. Svensson L., Howarth K., McDowall A., Patzak I., Evans R., Ussar S., Moser M., Metin A., Fried M., Tomlinson I., Hogg N. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat. Med. 2009, 15:306.
42. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008, 9:503.
43. Voskoboinik I., Smyth M.J., Trapani J.A. Perforin-mediated target-cell death and immune homeostasis. Nat. Rev. Immunol. 2006, 6:940.
44. Whiteside T.L., Herberman R.B. The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 1995, 7:704.
45. Wood S.M., Meeths M., Chiang S.C., Bechensteen A.G., Boelens J.J., Heilmann C., Horiuchi H., Rosthoj S., Rutynowska O., Winiarski J., Stow J.L., Nordenskjold M., Henter J.I., Ljunggren H.G., Bryceson Y.T. Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity. Blood 2009, 114:4117.